Home Healthcare Pharmaceuticals Drug Repurposing Market

Drug Repurposing Market Size, Share & Trends Analysis Report By Method (Drug Centric, Disease Centric, Target Centric), By Application (Oncology, Autoimmune Diseases, Rare Diseases, Others), By End-User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Academic and Research Institutions) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: May 25, 2026 | Author: Mitiksha Koul | Format: | Report Code: SR6804DR | Pages: 155
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Drug Repurposing Market, By Method 2022-2034 (USD MILLION/ Units)
    1. Drug Centric
    2. Disease Centric
    3. Target Centric
  2. Drug Repurposing Market, By Application 2022-2034 (USD MILLION/ Units)
    1. Oncology
    2. Autoimmune Diseases
    3. Rare Diseases
    4. Others
  3. Drug Repurposing Market, By End-User 2022-2034 (USD MILLION/ Units)
    1. Pharmaceutical & Biotechnology Companies
    2. Contract Research Organizations
    3. Academic and Research Institutions
  4. Regional Drug Repurposing Market
    1. North America
      1. North America Drug Repurposing Market By Method 2022-2034 (USD MILLION/ Units)
        1. Drug Centric
        2. Disease Centric
        3. Target Centric
      2. North America Drug Repurposing Market By Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Autoimmune Diseases
        3. Rare Diseases
        4. Others
      3. North America Drug Repurposing Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Contract Research Organizations
        3. Academic and Research Institutions
      4. U.S.
        1. Drug Centric
        2. Disease Centric
        3. Target Centric
        4. Oncology
        5. Autoimmune Diseases
        6. Rare Diseases
        7. Others
        8. Pharmaceutical & Biotechnology Companies
        9. Contract Research Organizations
        10. Academic and Research Institutions
      5. Canada
        1. Drug Centric
        2. Disease Centric
        3. Target Centric
        4. Oncology
        5. Autoimmune Diseases
        6. Rare Diseases
        7. Others
        8. Pharmaceutical & Biotechnology Companies
        9. Contract Research Organizations
        10. Academic and Research Institutions
    2. Europe
      1. Europe Drug Repurposing Market By Method 2022-2034 (USD MILLION/ Units)
        1. Drug Centric
        2. Disease Centric
        3. Target Centric
      2. Europe Drug Repurposing Market By Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Autoimmune Diseases
        3. Rare Diseases
        4. Others
      3. Europe Drug Repurposing Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Contract Research Organizations
        3. Academic and Research Institutions
      4. U.K.
        1. Drug Centric
        2. Disease Centric
        3. Target Centric
        4. Oncology
        5. Autoimmune Diseases
        6. Rare Diseases
        7. Others
        8. Pharmaceutical & Biotechnology Companies
        9. Contract Research Organizations
        10. Academic and Research Institutions
      5. Germany
        1. Drug Centric
        2. Disease Centric
        3. Target Centric
        4. Oncology
        5. Autoimmune Diseases
        6. Rare Diseases
        7. Others
        8. Pharmaceutical & Biotechnology Companies
        9. Contract Research Organizations
        10. Academic and Research Institutions
      6. France
        1. Drug Centric
        2. Disease Centric
        3. Target Centric
        4. Oncology
        5. Autoimmune Diseases
        6. Rare Diseases
        7. Others
        8. Pharmaceutical & Biotechnology Companies
        9. Contract Research Organizations
        10. Academic and Research Institutions
      7. Spain
        1. Drug Centric
        2. Disease Centric
        3. Target Centric
        4. Oncology
        5. Autoimmune Diseases
        6. Rare Diseases
        7. Others
        8. Pharmaceutical & Biotechnology Companies
        9. Contract Research Organizations
        10. Academic and Research Institutions
      8. Italy
        1. Drug Centric
        2. Disease Centric
        3. Target Centric
        4. Oncology
        5. Autoimmune Diseases
        6. Rare Diseases
        7. Others
        8. Pharmaceutical & Biotechnology Companies
        9. Contract Research Organizations
        10. Academic and Research Institutions
      9. Russia
        1. Drug Centric
        2. Disease Centric
        3. Target Centric
        4. Oncology
        5. Autoimmune Diseases
        6. Rare Diseases
        7. Others
        8. Pharmaceutical & Biotechnology Companies
        9. Contract Research Organizations
        10. Academic and Research Institutions
      10. Nordic
        1. Drug Centric
        2. Disease Centric
        3. Target Centric
        4. Oncology
        5. Autoimmune Diseases
        6. Rare Diseases
        7. Others
        8. Pharmaceutical & Biotechnology Companies
        9. Contract Research Organizations
        10. Academic and Research Institutions
      11. Benelux
        1. Drug Centric
        2. Disease Centric
        3. Target Centric
        4. Oncology
        5. Autoimmune Diseases
        6. Rare Diseases
        7. Others
        8. Pharmaceutical & Biotechnology Companies
        9. Contract Research Organizations
        10. Academic and Research Institutions
      12. Rest of Europe
        1. Drug Centric
        2. Disease Centric
        3. Target Centric
        4. Oncology
        5. Autoimmune Diseases
        6. Rare Diseases
        7. Others
        8. Pharmaceutical & Biotechnology Companies
        9. Contract Research Organizations
        10. Academic and Research Institutions
    3. APAC
      1. APAC Drug Repurposing Market By Method 2022-2034 (USD MILLION/ Units)
        1. Drug Centric
        2. Disease Centric
        3. Target Centric
      2. APAC Drug Repurposing Market By Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Autoimmune Diseases
        3. Rare Diseases
        4. Others
      3. APAC Drug Repurposing Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Contract Research Organizations
        3. Academic and Research Institutions
      4. China
        1. Drug Centric
        2. Disease Centric
        3. Target Centric
        4. Oncology
        5. Autoimmune Diseases
        6. Rare Diseases
        7. Others
        8. Pharmaceutical & Biotechnology Companies
        9. Contract Research Organizations
        10. Academic and Research Institutions
      5. Korea
        1. Drug Centric
        2. Disease Centric
        3. Target Centric
        4. Oncology
        5. Autoimmune Diseases
        6. Rare Diseases
        7. Others
        8. Pharmaceutical & Biotechnology Companies
        9. Contract Research Organizations
        10. Academic and Research Institutions
      6. Japan
        1. Drug Centric
        2. Disease Centric
        3. Target Centric
        4. Oncology
        5. Autoimmune Diseases
        6. Rare Diseases
        7. Others
        8. Pharmaceutical & Biotechnology Companies
        9. Contract Research Organizations
        10. Academic and Research Institutions
      7. India
        1. Drug Centric
        2. Disease Centric
        3. Target Centric
        4. Oncology
        5. Autoimmune Diseases
        6. Rare Diseases
        7. Others
        8. Pharmaceutical & Biotechnology Companies
        9. Contract Research Organizations
        10. Academic and Research Institutions
      8. Australia
        1. Drug Centric
        2. Disease Centric
        3. Target Centric
        4. Oncology
        5. Autoimmune Diseases
        6. Rare Diseases
        7. Others
        8. Pharmaceutical & Biotechnology Companies
        9. Contract Research Organizations
        10. Academic and Research Institutions
      9. Taiwan
        1. Drug Centric
        2. Disease Centric
        3. Target Centric
        4. Oncology
        5. Autoimmune Diseases
        6. Rare Diseases
        7. Others
        8. Pharmaceutical & Biotechnology Companies
        9. Contract Research Organizations
        10. Academic and Research Institutions
      10. South East Asia
        1. Drug Centric
        2. Disease Centric
        3. Target Centric
        4. Oncology
        5. Autoimmune Diseases
        6. Rare Diseases
        7. Others
        8. Pharmaceutical & Biotechnology Companies
        9. Contract Research Organizations
        10. Academic and Research Institutions
      11. Rest of Asia-Pacific
        1. Drug Centric
        2. Disease Centric
        3. Target Centric
        4. Oncology
        5. Autoimmune Diseases
        6. Rare Diseases
        7. Others
        8. Pharmaceutical & Biotechnology Companies
        9. Contract Research Organizations
        10. Academic and Research Institutions
    4. Middle East and Africa
      1. Middle East and Africa Drug Repurposing Market By Method 2022-2034 (USD MILLION/ Units)
        1. Drug Centric
        2. Disease Centric
        3. Target Centric
      2. Middle East and Africa Drug Repurposing Market By Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Autoimmune Diseases
        3. Rare Diseases
        4. Others
      3. Middle East and Africa Drug Repurposing Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Contract Research Organizations
        3. Academic and Research Institutions
      4. UAE
        1. Drug Centric
        2. Disease Centric
        3. Target Centric
        4. Oncology
        5. Autoimmune Diseases
        6. Rare Diseases
        7. Others
        8. Pharmaceutical & Biotechnology Companies
        9. Contract Research Organizations
        10. Academic and Research Institutions
      5. Turkey
        1. Drug Centric
        2. Disease Centric
        3. Target Centric
        4. Oncology
        5. Autoimmune Diseases
        6. Rare Diseases
        7. Others
        8. Pharmaceutical & Biotechnology Companies
        9. Contract Research Organizations
        10. Academic and Research Institutions
      6. Saudi Arabia
        1. Drug Centric
        2. Disease Centric
        3. Target Centric
        4. Oncology
        5. Autoimmune Diseases
        6. Rare Diseases
        7. Others
        8. Pharmaceutical & Biotechnology Companies
        9. Contract Research Organizations
        10. Academic and Research Institutions
      7. South Africa
        1. Drug Centric
        2. Disease Centric
        3. Target Centric
        4. Oncology
        5. Autoimmune Diseases
        6. Rare Diseases
        7. Others
        8. Pharmaceutical & Biotechnology Companies
        9. Contract Research Organizations
        10. Academic and Research Institutions
      8. Egypt
        1. Drug Centric
        2. Disease Centric
        3. Target Centric
        4. Oncology
        5. Autoimmune Diseases
        6. Rare Diseases
        7. Others
        8. Pharmaceutical & Biotechnology Companies
        9. Contract Research Organizations
        10. Academic and Research Institutions
      9. Nigeria
        1. Drug Centric
        2. Disease Centric
        3. Target Centric
        4. Oncology
        5. Autoimmune Diseases
        6. Rare Diseases
        7. Others
        8. Pharmaceutical & Biotechnology Companies
        9. Contract Research Organizations
        10. Academic and Research Institutions
      10. Rest of MEA
        1. Drug Centric
        2. Disease Centric
        3. Target Centric
        4. Oncology
        5. Autoimmune Diseases
        6. Rare Diseases
        7. Others
        8. Pharmaceutical & Biotechnology Companies
        9. Contract Research Organizations
        10. Academic and Research Institutions
    5. LATAM
      1. LATAM Drug Repurposing Market By Method 2022-2034 (USD MILLION/ Units)
        1. Drug Centric
        2. Disease Centric
        3. Target Centric
      2. LATAM Drug Repurposing Market By Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Autoimmune Diseases
        3. Rare Diseases
        4. Others
      3. LATAM Drug Repurposing Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Contract Research Organizations
        3. Academic and Research Institutions
      4. Brazil
        1. Drug Centric
        2. Disease Centric
        3. Target Centric
        4. Oncology
        5. Autoimmune Diseases
        6. Rare Diseases
        7. Others
        8. Pharmaceutical & Biotechnology Companies
        9. Contract Research Organizations
        10. Academic and Research Institutions
      5. Mexico
        1. Drug Centric
        2. Disease Centric
        3. Target Centric
        4. Oncology
        5. Autoimmune Diseases
        6. Rare Diseases
        7. Others
        8. Pharmaceutical & Biotechnology Companies
        9. Contract Research Organizations
        10. Academic and Research Institutions
      6. Argentina
        1. Drug Centric
        2. Disease Centric
        3. Target Centric
        4. Oncology
        5. Autoimmune Diseases
        6. Rare Diseases
        7. Others
        8. Pharmaceutical & Biotechnology Companies
        9. Contract Research Organizations
        10. Academic and Research Institutions
      7. Chile
        1. Drug Centric
        2. Disease Centric
        3. Target Centric
        4. Oncology
        5. Autoimmune Diseases
        6. Rare Diseases
        7. Others
        8. Pharmaceutical & Biotechnology Companies
        9. Contract Research Organizations
        10. Academic and Research Institutions
      8. Colombia
        1. Drug Centric
        2. Disease Centric
        3. Target Centric
        4. Oncology
        5. Autoimmune Diseases
        6. Rare Diseases
        7. Others
        8. Pharmaceutical & Biotechnology Companies
        9. Contract Research Organizations
        10. Academic and Research Institutions
      9. Rest of LATAM
        1. Drug Centric
        2. Disease Centric
        3. Target Centric
        4. Oncology
        5. Autoimmune Diseases
        6. Rare Diseases
        7. Others
        8. Pharmaceutical & Biotechnology Companies
        9. Contract Research Organizations
        10. Academic and Research Institutions
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.